Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Apr 2010 for FACET BIOTECH CORP, €434k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Mark Rolfe: trading record in brief
All filings by Mark Rolfe on record concern Facet Biotech Corp. In total, 3 filings cover trades dated from 20 August 2009 to 21 April 2010.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 23 April 2010: a transaction of €434k, in Facet Biotech Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Rolfe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
21,333 shares@ US$27.00Comon StockSEC:0001441848-10-000023:0
1,113 shares@ US$27.00Common StockSEC:0001441848-10-000006:0
21,333 shares0Common StockSEC:0001441848-09-000042:0
3 of 3 declarations
